Skip to main content
Log in

Acute care costly in AD pre-diagnosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Geldmacher DS, et al. Pre-Diagnosis Excess Acute Care Costs in Alzheimer's Patients among a US Medicaid Population. Applied Health Economics and Health Policy : 23 May 2013. Available from: URL: http://dx.doi.org/10.1007/s40258-013-0038-9

Download references

Additional information

*funded by Bayer HealthCare Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Acute care costly in AD pre-diagnosis. PharmacoEcon Outcomes News 680, 12 (2013). https://doi.org/10.1007/s40274-013-0481-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0481-8

Navigation